Umb Gene Research & Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4.83%
(FY 2022)
- Profit -16.02%
(FY 2022)
- Ebitda -17.13%
(FY 2022)
- Net Worth 82.60%
(FY 2022)
- Total Assets 60.31%
(FY 2022)
About Umb Gene Research & Pharma
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hita Sharma and Sidharath Kumar serve as directors at the Company.
- CIN/LLPIN
U73100HR2020PTC090031
- Company No.
090031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Rohtak, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Umb Gene Research & Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hita Sharma  | Director | 12-Oct-2020 | Current |
| Sidharath Kumar | Director | 12-Oct-2020 | Current |
Financial Performance and Corporate Structure Insights of Umb Gene Research & Pharma.
Umb Gene Research & Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.83% increase. The company also saw a substantial fall in profitability, with a 16.02% decrease in profit. The company's net worth Soared by an impressive increase of 82.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Umb Gene Research & Pharma?
Unlock access to Umb Gene Research & Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Umb Gene Research & Pharma?
Umb Gene Research & Pharma has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umb Gene Research & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umb Gene Research & Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
